Kruithof, E <br/><br/>
Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up.  [electronic resource] 

 -  Annals of the rheumatic diseases  Mar 2002 
 - 207-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-4967 
<br/><br/><label>Standard No.: </label>10.1136/ard.61.3.207  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Antinuclear--immunology<br/>Antibodies, Monoclonal--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Female<br/>Fluorescent Antibody Technique, Indirect<br/>Follow-Up Studies<br/>Humans<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Retreatment<br/>Spondylarthropathies--drug therapy<br/>Statistics, Nonparametric<br/>Treatment Outcome